期刊文献+

拮抗剂与高孕激素下促排卵方案用于多囊卵巢综合征患者IVF治疗效果比较 被引量:23

Comparison of IVF efficacy between GnRH antagonist protocol and progestin-primed ovarian stimulation protocol in PCOS patients
下载PDF
导出
摘要 目的比较拮抗剂方案与高孕激素状态下促排卵(PPOS)方案在多囊卵巢综合征(PCOS)患者行IVF助孕治疗中的应用效果。方法回顾性分析2016年11月至2017年11月在本院行IVF助孕治疗的138例单纯PCOS不孕症患者的临床资料,根据促排卵方案的不同将患者分为两组:PPOS组(57例)和拮抗剂组(81例)。比较两组患者的一般资料、促排卵情况及胚胎实验室指标。结果两组患者的年龄、月经周期、不孕年限、体重指数(BMI)、基础窦卵泡数、基础FSH、基础LH及基础E2等比较均无显著性差异(P>0.05)。拮抗剂组的Gn总量显著低于PPOS组[(1 725.5±612.9)vs.(2 147.3±811.5)U],早发LH峰发生率(7.4%vs.0%)、直径≥14mm卵泡数[(15.2±8.2)vs.(12.7±7.2)个]、E2峰值[(16 573.7±8 844.7)vs.(12 980.8±7 486.8)pmol/L]、HCG日孕酮(P)水平[(3.15±1.53)vs.(2.68±1.53)nmol/L]、获卵数[(17.2±9.7)vs.(13.0±8.3)个]、轻中度OHSS发生率(6.2%vs.0%)均显著高于PPOS组(P<0.05)。两组间的Gn用药天数、2PN受精率、卵裂率、优质胚胎数、重度OHSS发生率比较均无显著性差异(P>0.05)。结论 PPOS方案能获得与拮抗剂方案相似的优质胚胎数,且能更好地抑制早发LH峰,减少轻中度OHSS发生率,可作为PCOS患者促排卵方案的选择之一。 Objective : To compare the IVF efficacy between GnRH antagonist (GnRH-ant) protocol and progestin-primed ovarian stimulation (PPOS) protocol in patients with polycystic ovary syndrome (PCOS).Methods : A retrospective study was performed including 138 PCOS patients undergone IVF treatment in our center from November 2016 to November 2017.Among them,81 cycles were in GnRH-ant protocol group and 57 cycles in PPOS protocol group.The clinical characteristic of patients and the efficacy of the controlled ovarian hyperstimulation (COH) were compared between the two groups.Results : There were no significant differences in age,menstrual cycle,infertility years,body mass index (BMI),number of basal antral follicles,basal levels of FSH,LH and E 2 between the two groups ( P 〉0.05).The total amount of gonadotropin (Gn) used [(1 725.5±612.9) vs.(2 147.3±811.5) U],the occurrence of premature LH surge(7.4% vs.0%),the number of follicles with diameter ≥14 mm [(15.2±8.2)vs.(12.7±7.2)],the E 2 peak level [(16 573.7±8 844.7)vs.(12 980.8±7 486.8) pmol/L],the progesterone level on the HCG day [(3.15±1.53)vs.(2.68±1.53) nmol/L],the number of oocyte retrieved [(17.2±9.7)vs.(13.0±8.3)] and the incidence of mild-to-moderate OHSS(6.2% vs.0% )in GnRH-ant protocol group were significantly higher than those in PPOS protocol group ( P 〈0.05).There was no significant difference in stimulation days,2PN fertilization rate,cleavage rate,number of good quality embryo,and the incidence of severe OHSS between the two groups.Conclusions : PPOS protocol can obtain similar number of good quality embryos compared with GnRH-ant protocol,and effectively inhibit the premature LH surge and the incidence of mild-to-moderate OHSS.Therefore,PPOS can be used as one of the choices for ovulation induction in patients with PCOS.
作者 肖卓妮 杨菁 徐望明 李风和 XIAO Zhuo-ni;YANG Jing;XU Wang-ming;LI Feng-he(Centre for Reproductive Medicine,Renmin Hospital of Wuhan University,Clinical Research Center for Reproductive Medicine and Embryo Development of Hubei Province,Wuhan 43006)
出处 《生殖医学杂志》 CAS 2018年第12期1170-1174,共5页 Journal of Reproductive Medicine
基金 国家自然科学基金(81471455 81100418)
关键词 多囊卵巢综合征 高孕激素状态下促排卵方案 拮抗剂方案 控制性超促排卵 Polycystic ovary syndrome (PCOS) Progestin-primed ovarian stimulation (PPOS) GnRH antagonist protocol Controlled ovarian hyperstimulation(COH)
  • 相关文献

参考文献4

二级参考文献48

  • 1March WA, Moore VM, Willson K J, et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod, 2010, 25 (2):544-51.
  • 2Rebar R, Judd HL, Yen SS, et al. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J Clin Invest, 1976, 57(9): 1320-9.
  • 3Taylor AE, Mccourt B, Martin KA, et al. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab, 1997, 82(7):2248-56.
  • 4Urman B, Tiras B, Yakin K. Assisted reproduction in the treatment of polyeystic ovarian syndrome. Reprod Biomed Online, 2004, 8(4):419-30.
  • 5Santos MA, Kuijk EW, Macklon NS. The impact of ovarian stimulation for IVF on the developing embryo. Hum Reprod, 2010, 139(1):23-34.
  • 6Homburg R. Adverse effects of luteinizing hormone on fertility: fact or fantasy. Baillieres Clin Obstet Gynaecol, 1998, 12 (4):555-63.
  • 7Balen AH. Hypersecretion of luteinizing hormone and the po|ycystic ovary syndrome. Hum Reprod, 1993, 8(Suppl 2): 123-8.
  • 8Backos M, E1-Gaddal S, Nardo LG, et al. High serum luteinizing hormone and testosterone concentrations do not predict pregnancy outcome in women with recurrent miscarriage. Fertil Steril, 2002, 77(2):348-52.
  • 9Mee WK, Sebastiaan M, Sjoerd R. Cryopreservation of human embryos and its contribution to in vitro fertilization success rates. Fertil Steril, 2014, 102(1):19-26.
  • 10Zhu XX, Zhang XL, Fu YL. Utrogestan as an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimu- lation for in vitro fertilization. Medicine, 2015, 94(21): 1-8.

共引文献90

同被引文献143

引证文献23

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部